Bethany Davis, RN in North Clarendon, VT - Registered Nurse

Bethany Davis, RN is a Registered Nurse based in North Clarendon, Vermont. Bethany Davis is licensed to practice in Vermont (license number 026.0087395) and her current practice location is 71 Pluss Ln, North Clarendon, Vermont. She can be reached at her office (for appointments etc.) via phone at (802) 324-3979.

NPI number for Bethany Davis is 1336570399 and her current mailing address is 71 Pluss Ln, North Clarendon, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1336570399.

Contact Information

	Bethany Davis, RN
	71 Pluss Ln, North Clarendon, VT 05759-9629
	(802) 324-3979
	Not Available

Provider's Profile

Full Name	Bethany Davis
Gender	Female
Speciality	Registered Nurse
Location	71 Pluss Ln, North Clarendon, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1336570399
Provider Enumeration Date: 12/02/2013
Last Update Date: 12/02/2013

Medical Identifiers

Medical identifiers for Bethany Davis such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336570399	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163W00000X	Registered Nurse	026.0087395 (Vermont)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bethany Davis is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Bethany Davis, RN 71 Pluss Ln, North Clarendon, VT 05759-9629 Ph: (802) 324-3979	Bethany Davis, RN 71 Pluss Ln, North Clarendon, VT 05759-9629 Ph: (802) 324-3979

News Archive

European infusion therapy device market to reach €533 million by 2017: New report

According to a new report by iData Research, the leading global authority in medical device market research, the European infusion therapy device market, which includes needleless connectors, infusion pumps and intravenous (IV) sets, was valued at an estimated €443 million in 2010.

Roundup: States grapple with high health costs, Medicaid squeeze

Gov. Scott Walker's budget repair bill would give his administration sweeping powers to reshape state health programs covering more than 1 million state residents. Under the bill, the administration's rewrite of the Medicaid program would be reviewed only by the Legislature's budget committee, which has a broader margin of control for majority Republican lawmakers than any other legislative committee.

Groundbreaking experimental therapy has ability to suppress ulcerative colitis

UCLA scientists have discovered a groundbreaking experimental therapy that has the ability to suppress the development of ulcerative colitis (UC), a disease which causes inflammation in the digestive tract and colon cancer. The treatment utilizes a chemical inhibitor able to block an RNA molecule (microRNA-214) involved in the transmission of genetic information.

NBCH's annual report: How America's health plans are doing to improve care and control costs for diabetes

Today the National Business Coalition on Health issued its annual report on how America's health plans are doing to improve care and control costs for diabetes. The analysis is based on health plan survey data from NBCH's eValue8™ program, the nation's leading Request for Information (RFI) tool used by employers, coalitions and their purchaser members to set expectations and measure health plan performance.

Bethany Davis, RN - Registered Nurse in North Clarendon, VT